Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1981 1
1997 2
1999 1
2000 2
2001 1
2002 1
2004 2
2005 1
2008 1
2009 2
2011 2
2012 4
2013 1
2014 3
2015 2
2016 4
2017 4
2018 3
2019 3
2020 7
2021 7
2022 5
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for brain loza
Your search for Brian Loza retrieved no results
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, Nicolaes G, Wiewel M, Schultz M, Wildhag… See abstract for full author list ➔ Bateman RM, et al. Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6. Crit Care. 2016. PMID: 27885969 Free PMC article.
Briones, F. Rodriguez de Castro, C. Rodriguez Gallego P003 - Brain protective effects of intravenous immunoglobulin through inhibition of complement activation and apoptosis in a rat model of sepsis F. ...Pinsky P149 - Peripherally inserted central catheters placed in the …
Briones, F. Rodriguez de Castro, C. Rodriguez Gallego P003 - Brain protective effects of intravenous immunoglobulin through inhibitio …
Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models.
Costa-Machado LF, Garcia-Dominguez E, McIntyre RL, Lopez-Aceituno JL, Ballesteros-Gonzalez Á, Tapia-Gonzalez A, Fabregat-Safont D, Eisenberg T, Gomez J, Plaza A, Sierra-Ramirez A, Perez M, Villanueva-Bermejo D, Fornari T, Loza MI, Herradon G, Hofer SJ, Magnes C, Madeo F, Duerr JS, Pozo OJ, Galindo MI, Del Pino I, Houtkooper RH, Megias D, Viña J, Gomez-Cabrera MC, Fernandez-Marcos PJ. Costa-Machado LF, et al. Nat Commun. 2023 May 15;14(1):2779. doi: 10.1038/s41467-023-38410-y. Nat Commun. 2023. PMID: 37188705 Free PMC article.
Treatment with harmol induces a transient mitochondrial depolarization, a strong mitophagy response, and the AMPK compensatory pathway both in cultured C2C12 myotubes and in male mouse liver, brown adipose tissue and muscle, even though harmol crosses poorly the blood-brain …
Treatment with harmol induces a transient mitochondrial depolarization, a strong mitophagy response, and the AMPK compensatory pathway both …
A novel mechanism of neuroprotection: Blood glutamate grabber.
Castillo J, Loza MI, Mirelman D, Brea J, Blanco M, Sobrino T, Campos F. Castillo J, et al. J Cereb Blood Flow Metab. 2016 Feb;36(2):292-301. doi: 10.1177/0271678X15606721. Epub 2015 Oct 2. J Cereb Blood Flow Metab. 2016. PMID: 26661174 Free PMC article. Review.
Several strategies have been developed against glutamate excitotoxicity, however none of them have not shown positive results in the clinical practice so far. Nowadays, the concept of blood/brain glutamate grabbing or scavenging is well recognized as a novel and attractive …
Several strategies have been developed against glutamate excitotoxicity, however none of them have not shown positive results in the clinica …
Reelin Signaling and Synaptic Plasticity in Schizophrenia.
Markiewicz R, Markiewicz-Gospodarek A, Borowski B, Trubalski M, Łoza B. Markiewicz R, et al. Brain Sci. 2023 Dec 11;13(12):1704. doi: 10.3390/brainsci13121704. Brain Sci. 2023. PMID: 38137152 Free PMC article. Review.
Collaboration and knowledge integration for successful brain therapeutics - lessons learned from the pandemic.
Loza MI, Hmeljak J, Bountra C, Audia JE, Chowdhury S, Weiman S, Merchant K, Blanco MJ. Loza MI, et al. Dis Model Mech. 2022 Dec 1;15(12):dmm049755. doi: 10.1242/dmm.049755. Epub 2022 Dec 21. Dis Model Mech. 2022. PMID: 36541917 Free PMC article.
Brain diseases are a major cause of death and disability worldwide and contribute significantly to years of potential life lost. ...As stakeholders from a broad range of scientific professions, we feel an urgency to advance brain disease therapies and encourage read …
Brain diseases are a major cause of death and disability worldwide and contribute significantly to years of potential life lost. ...A …
In vitro models for neuropathic pain phenotypic screening in brain therapeutics.
Martínez AL, Brea J, López D, Cosme N, Barro M, Monroy X, Burgueño J, Merlos M, Loza MI. Martínez AL, et al. Pharmacol Res. 2024 Apr;202:107111. doi: 10.1016/j.phrs.2024.107111. Epub 2024 Feb 19. Pharmacol Res. 2024. PMID: 38382648 Free article. Review.
The discovery of brain therapeutics faces a significant challenge due to the low translatability of preclinical results into clinical success. ...
The discovery of brain therapeutics faces a significant challenge due to the low translatability of preclinical results into clinical …
Clinical validation of blood/brain glutamate grabbing in acute ischemic stroke.
da Silva-Candal A, Pérez-Díaz A, Santamaría M, Correa-Paz C, Rodríguez-Yáñez M, Ardá A, Pérez-Mato M, Iglesias-Rey R, Brea J, Azuaje J, Sotelo E, Sobrino T, Loza MI, Castillo J, Campos F. da Silva-Candal A, et al. Ann Neurol. 2018 Aug;84(2):260-273. doi: 10.1002/ana.25286. Epub 2018 Aug 22. Ann Neurol. 2018. PMID: 30014516 Clinical Trial.
OBJECTIVE: Blood/brain-glutamate grabbing is an emerging concept in the treatment of acute ischemic stroke, where essentially the deleterious effects of glutamate after ischemia are ameliorated by coaxing glutamate to enter the bloodstream and thus reducing its concentrati …
OBJECTIVE: Blood/brain-glutamate grabbing is an emerging concept in the treatment of acute ischemic stroke, where essentially the del …
Nose-to-brain delivery of enveloped RNA - cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases.
Samaridou E, Walgrave H, Salta E, Álvarez DM, Castro-López V, Loza M, Alonso MJ. Samaridou E, et al. Biomaterials. 2020 Feb;230:119657. doi: 10.1016/j.biomaterials.2019.119657. Epub 2019 Dec 6. Biomaterials. 2020. PMID: 31837821
Direct nose-to-brain (N-to-B) delivery enables the rapid transport of drugs to the brain, while minimizing systemic exposure. ...
Direct nose-to-brain (N-to-B) delivery enables the rapid transport of drugs to the brain, while minimizing systemic exposure. …
Brain-derived neurotrophic factor and matrix metalloproteinase-9 activity during rehabilitation therapy of schizophrenic patients - environmental pilot study.
Markiewicz R, Markiewicz-Gospodarek AA, Dobrowolska B, Bojar I, Łoza B. Markiewicz R, et al. Ann Agric Environ Med. 2023 Jun 26;30(2):315-321. doi: 10.26444/aaem/163327. Epub 2023 May 2. Ann Agric Environ Med. 2023. PMID: 37387382 Free article.
INTRODUCTION AND OBJECTIVE: The aim of the study was to evaluate the peripheral level of brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) during rehabilitation therapy, combined with neurofeedback in schizophrenic patients, and to investigate …
INTRODUCTION AND OBJECTIVE: The aim of the study was to evaluate the peripheral level of brain-derived neurotrophic factor (BDNF) and …
66 results